FindTrial
Sign In

Effect of perioperative application of ascorbic acid for postoperative pulmonary complications in patients undergoing cardiac surgery

Effect of perioperative application of ascorbic acid for postoperative pulmonary complications in patients undergoing cardiac surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800019577
Enrollment
Unknown
Registered
2018-11-18
Start date
2018-12-01
Completion date
Unknown
Last updated
2018-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Self-raising

Interventions

Group A:Perioperative intravenous ascorbic acid 2g / day
Group A:Perioperative intravenous injection of normal saline 2g / day

Sponsors

Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. aged between 18-60 years old; 2. elective cardiopulmonary bypass patients undergoing cardiac surgery.

Exclusion criteria

Exclusion criteria: 1. emergency surgery patients; 2. patients with a history of cardiac surgery; 3. patients with severe lung disease; 4. BMI>30 or 40mmhg; 5. patients with ascorbic acid allergy; 6. urinary calculi patients; 7. Participate in other experiments.

Design outcomes

Primary

MeasureTime frame
Postoperative pulmonary complications score;—

Countries

China

Contacts

Public ContactJindong Liu

Xuzhou Medical University

Liujindong1818@163.com+86 13951355136

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026